Cheetah Medical said today it inked a supplier contract with non-for-profit healthcare system Allina Health.
Through the contract, Minnesota and western Wisconsin based Allina Health will gain access to Cheetah Medical’s hemodynamic monitoring solutions to help guide volume management decisions in septic patients, Cheetah Medical said.
“Intravenous fluid requirements vary significantly between patients based on underlying health conditions, and it can be a challenge to determine the right amount of fluid needed to properly maintain organ perfusion and optimize care. The Cheetah Medical technology has demonstrated value in addressing this challenge and we have made it a part of our system-wide sepsis management protocol at Allina Health,” Allina Health sepsis program medical director Dr. Jeff Dichter said in a press release.
The company’s technology, developed out of Israel, displays cardiac output and stroke volume non-invasively, which can aid in making volume-related decisions for patients with sepsis. The device allows clinicians to measure and see cardiac output to aid in volume-decisions, such as IV fluid or how to resuscitate patients, which can be critical for sepsis patients.
“We are proud to be working with Allina Health, and system wide relationships like we enjoy with Allina Health have driven significant growth for Cheetah Medical over the past couple years. Our products significantly reduce the barriers of bringing advanced hemodyamic monitoring to patients in the emergency, critical care and surgical settings. We believe that our technology can help Allina Health address the volume management challenges associated with sepsis,” Cheetah Medical CEO Chris Hutchison said in prepared remarks.
The company said it is also pursuing efforts to expand its presence outside of the U.S., signing distribution agreements covering 20 countries over the past 12 months.
Last November, Cheetah Medical said it is joining the Centers for Medicare and Medicaid Services in focusing on improving the treatment of sepsis in hospitals across the U.S.
The Centers for Medicare and Medicaid Services released new federal reporting requirements for treating hospitalized sepsis patients on October 1. The new rules aim to monitor how sepsis is managed within the U.S., and include data from more than 4,000 hospitals.
Cheetah Medical, based in Newton, Mass., thinks its technology platform can help improve the outcomes for these patients by giving clinicians more data to aid in critical-care decisions.
